(Press-News.org) Genetic findings support observational evidence that lower vitamin D levels are associated with increased risk of multiple sclerosis, according to a new research article by Brent Richards, from McGill University, Canada, and colleagues published this week in PLOS Medicine.
Multiple sclerosis is a debilitating autoimmune disease that affects the nerves in the brain and spinal cord. There is no known cure for multiple sclerosis and it usually presents between the ages of 20 and 40 years. While some observational evidence suggests there may be a link between lower vitamin D levels and multiple sclerosis risk, it is difficult to infer a causal relationship because individuals who develop multiple sclerosis in these studies might share another unknown characteristic that increases their risk of multiple sclerosis (this is known as confounding).
Using a genetic technique called Mendelian randomization to reduce the possibility of confounding the authors examined whether there was an association between genetically reduced vitamin D levels (measured by the level of 25-hydroxyvitamin D, the clinical determinant of vitamin D status) and susceptibility to multiple sclerosis among participants in the International Multiple Sclerosis Genetics Consortium study, which involves 14,498 people with multiple sclerosis and 24,091 healthy controls. The authors found that a genetic decrease in the natural-log-transformed vitamin D level by one standard deviation was associated with a 2-fold increased risk of multiple sclerosis.
While the Mendelian randomization approach used by the authors largely avoids the possibility of confounding or reverse causation, the reliability of these findings may be limited by some of the assumptions made by the researchers during their analysis.
Nevertheless the authors conclude, "genetically lowered vitamin D levels are strongly associated with increased susceptibility to multiple sclerosis. Whether vitamin D sufficiency can delay, or prevent, multiple sclerosis onset merits further investigation in long-term randomized controlled trials."
The authors also note, "ongoing randomized controlled trials are currently assessing vitamin D supplementation for the treatment and prevention of multiple sclerosis ... and may therefore provide needed insights into the role of vitamin D supplementation."
INFORMATION:
Research Article
Funding: JBR is funded by the Canadian Institute of Health Research, (MOP-119462) The Fonds de la Recherche en Santé Québec, the Lady Davis Institute, and the Jewish General Hospital. AL is supported by the Canadian Diabetes Association Postdoctoral Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Competing Interests: GT has accepted speaker's fees and consultancy fees from Servier Canada relating to the treatment of hypertension and has participated on an Advisory Board for ISIS Pharmaceuticals for the treatment of dyslipidemia. GT also receives research grants from the Canadian Institute of Health Research and the Heart and Stroke Foundation of Canada. GDS is a member of the Editorial Board of PLOS Medicine. None of these relationships relate to the content/topic of the manuscript under review at PLOS Medicine.
Citation: Mokry LE, Ross S, Ahmad OS, Forgetta V, Smith GD, Leong A, et al. (2015) Vitamin D and Risk of Multiple Sclerosis: A Mendelian Randomization Study. PLoS Med 12(8): e1001866. doi:10.1371/journal.pmed.1001866
Author Affiliations:
Centre for Clinical Epidemiology, Department of Epidemiology, Lady Davis Institute for Medical Research, Jewish General Hospital, McGill University, Montreal, Quebec, Canada
Department of Medicine, McGill University, Montreal, Quebec, Canada
MRC Integrative Epidemiology Unit, School of Social and Community Medicine, University of Bristol, Bristol, United Kingdom
Division of General Internal Medicine, Massachusetts General Hospital, Boston, Massachusetts, United States of America
Department of Medicine, Harvard Medical School, Boston, Massachusetts, United States of America
Department of Oncology, McGill University, Montreal, Quebec, Canada
Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Montreal, Quebec, Canada
Department of Human Genetics, McGill University, Montreal, Quebec, Canada
Lady Davis Institute, Jewish General Hospital, Montreal, Quebec, Canada
Preventive and Genomic Cardiology, McGill University Health Center, Montreal, QC
Department of Twin Research and Genetic Epidemiology, King's College London, United Kingdom
IN YOUR COVERAGE PLEASE USE THIS URL TO PROVIDE ACCESS TO THE FREELY AVAILABLE PAPER:
http://journals.plos.org/plosmedicine/article?id=10.1371/journal.pmed.1001866
Contact:
Emmanuelle Paciullo
Relations médias et gouvernementales | Media and Government Relations
Communications et relations médias | Communications and Media Relations
CIUSSS du Centre-Ouest-de-l'Ile-de-Montreal
Integrated Health & Social Services University Network for West-Central Montreal
T: 514-340-8222 poste 4120
Téléavertisseur: 514-413-1289 (urgences médias)
A new modeling study appearing this week in PLOS Medicine supports consideration of vaccination campaigns using a single dose of cholera vaccine versus campaigns using the recommended two doses given two weeks apart.. Justin Lessler and colleagues, of Johns Hopkins Bloomberg School of Health, Baltimore, Epicentre, Paris and Médecins Sans Frontières, Geneva focus their modelling analyses on comparing the number of lives that could be saved by adopting a single vaccine dose, which could be more rapidly administered to more people than the internationally licensed ...
An oral cholera vaccine that is in short supply could treat more people and save more lives in crisis situations, if one dose were dispensed instead of the recommended two, new Johns Hopkins Bloomberg School of Public Health research suggests.
More than 1.5 billion people around the world are at risk for cholera, a severe diarrheal illness caused by bacteria linked to poor water and sanitation. It is a major killer worldwide, causing an estimated two to three million cases and 100,000 deaths each year, primarily in developing nations.
A relatively new vaccine -- internationally ...
Evolutionary theory says mutations are blind and occur randomly. But in the phenomenon of adaptive mutation, cells can peek under the blindfold, increasing their mutation rate in response to stress.
Scientists at Winship Cancer Institute, Emory University have observed that an apparent "back channel" for genetic information called retromutagenesis can encourage adaptive mutation to take place in bacteria.
The results are scheduled for publication in PLOS Genetics on Tuesday, August 25.
"This mechanism may explain how bacteria develop resistance to some types of antibiotics ...
Tropical Cyclone Atsani appeared to look more like a frontal system in infrared imagery from NASA's Aqua satellite.Early on August 26, the Joint Typhoon Warning Center issued their final bulletin on the system as it was transitioning into an extra-tropical cyclone,
The Atmospheric Infrared Sounder or AIRS instrument that also flies aboard Aqua captured infrared data on the storm on August 25 at 14:47 UTC (10:47 a.m. EDT). Cloud top temperatures in thunderstorms northeast of the center were colder than -63F/-52C, indicating high, strong thunderstorms with the potential ...
Bats are natural reservoirs of several important emerging viruses, and because cross-species transmission appears to be quite common among bats, it's important to study bats in a community context rather than concentrating on individual species.
Researchers have now used such an approach to identify characteristics of cross-species virus transmission in bats and rodents, another important viral host. The investigators uncovered evidence to suggest that viruses pass more easily between bat species than between rodent species, and they found that characteristics unique ...
In a new review of all relevant medical research on breastfeeding practices, infants 0 to 5 months of age who were predominantly, partially, or not breastfed had 1.5-, 4.8-, and 14.4-times higher risks of dying, respectively, compared with exclusively breastfed infants. Also, children aged 6 to 23 months who were not breastfed had about a 2-times higher risk of dying than children who were continued on breastfeeding.
"The findings underscore the importance of optimal breastfeeding practices during infancy and early childhood," said Dr. M. Jeeva Sankar, lead author of ...
(Boston)--Twenty-five percent of men currently taking Finasteride or Dutasteride, popularly known as Proscar and Avodart, for the treatment of benign prostate enlargement (BPH), appear not to benefit from taking these medications. Those prescribed Propecia or Avodart for male pattern hair loss (known as alopecia) are also at risk for adverse events elicited by these drugs.
These findings are part of an international, collaborative review currently online in the journal Endocrine Reviews and Metabolic Disorders. Led by Abdulmaged Traish, PhD, professor of biochemistry ...
In early August, biologist Peter Ward returned from the South Pacific with news that he encountered an old friend, one he hadn't seen in over three decades. The University of Washington professor had seen what he considers one of the world's rarest animals, a remote encounter that may become even more infrequent if illegal fishing practices continue.
The creature in question is Allonautilus scrobiculatus, a species of nautilus that Ward and a colleague had previously discovered off of Ndrova Island in Papua New Guinea. Nautiluses are small, distant cousins of squid and ...
RIVERSIDE, Calif. - Barley, a widely grown cereal grain commonly used to make beer and other alcoholic beverages, possesses a large and highly repetitive genome that is difficult to fully sequence. Now a team led by scientists at the University of California, Riverside has reached a new milestone in its work, begun in 2000, on sequencing the barley genome. The researchers have sequenced large portions of the genome that together contain nearly two-thirds of all barley genes.
The new information, published in The Plant Journal, will not only expand geneticists' knowledge ...
A recent randomized trial conducted by researchers at Abbott Northwestern Hospital, part of Allina Health, found that inpatient palliative care (PC) visits were associated with improved quality of life and symptom burden for patients with heart failure (HF).
Because of these results, Abbott Northwestern conducted a new study, "A Description of Inpatient Palliative Care Actions for Patients with Acute Heart Failure," published June 30 by the American Journal of Hospice and Palliative Medicine. The study aimed to identify and describe what actions PC providers took to ...
